North American Industry Classification System (NAICS) code 325412 is used by federal buyers for market research, set-aside size standards, and reporting. Official titles come from the Census Bureau NAICS structure.
Official definition
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Official title
- Pharmaceutical Preparation Manufacturing
- Code level
- 6
- Parent industry
- Pharmaceutical and Medicine Manufacturing 32541
- Open opportunities
- 23 open · 598 active
SBA small-business size standard
1,300 employees
Employee-count basis
Check this standard and its exceptionsExcluded or separately classified activities
Official Census cross-references identify activities that belong under another North American Industry Classification System (NAICS) code.
Manufacturing in-vitro diagnostic substances--are classified in U.S. Industry 325413, In-Vitro Diagnostic Substance Manufacturing; and
Manufacturing uncompounded medicinal chemicals and their derivatives--are classified in U.S. Industry 325411, Medicinal and Botanical Manufacturing;
Manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except for diagnostic use)--are classified in U.S. Industry 325414, Biological Product (except Diagnostic) Manufacturing.
Source and edition
2022 NAICS Manual definition and reference material from the U.S. Census Bureau.